BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15604267)

  • 1. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
    Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
    Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma.
    Cui Y; Tian M; Zong M; Teng M; Chen Y; Lu J; Jiang J; Liu X; Han J
    Pancreatology; 2009; 9(1-2):89-98. PubMed ID: 19077459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins.
    Tian R; Wei LM; Qin RY; Li Y; Du ZY; Xia W; Shi CJ; Jin H
    Dig Dis Sci; 2008 Jan; 53(1):65-72. PubMed ID: 17492507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
    Chen J; Wu W; Chen L; Ma X; Zhao Y; Zhou H; Yang R; Hu L
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2175-9. PubMed ID: 25331466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells.
    Jesnowski R; Zubakov D; Faissner R; Ringel J; Hoheisel JD; Lösel R; Schnölzer M; Löhr M
    Neoplasia; 2007 Feb; 9(2):136-46. PubMed ID: 17356710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
    Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
    J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.
    Shekouh AR; Thompson CC; Prime W; Campbell F; Hamlett J; Herrington CS; Lemoine NR; Crnogorac-Jurcevic T; Buechler MW; Friess H; Neoptolemos JP; Pennington SR; Costello E
    Proteomics; 2003 Oct; 3(10):1988-2001. PubMed ID: 14625861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
    Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
    Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.
    Cui Y; Zhang D; Jia Q; Li T; Zhang W; Han J
    Cancer Invest; 2009 Aug; 27(7):747-55. PubMed ID: 19488907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
    Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
    Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
    Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
    BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples.
    Bloomston M; Zhou JX; Rosemurgy AS; Frankel W; Muro-Cacho CA; Yeatman TJ
    Cancer Res; 2006 Mar; 66(5):2592-9. PubMed ID: 16510577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue.
    Chen JH; Ni RZ; Xiao MB; Guo JG; Zhou JW
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):193-200. PubMed ID: 19357035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry.
    Mikuriya K; Kuramitsu Y; Ryozawa S; Fujimoto M; Mori S; Oka M; Hamano K; Okita K; Sakaida I; Nakamura K
    Int J Oncol; 2007 Apr; 30(4):849-55. PubMed ID: 17332923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.